Horacio Pappa
Horacio Pappa is senior director, US Pharmacopeia.
Articles
Ongoing Analytical Procedure Performance Verification—Stage 3 of USP<1220>
Phil Borman;Amanda Guiraldelli Mahr;Jane Weitzel;Sarah Thompson;Joachim Ermer;Stephanie Sproule;Jean-Marc Roussel;Jaime Marach;Horacio Pappa
March 2nd 2023Analytical procedure performance can be continually verified by risk-based monitoring of performance related data.
Latest Updated Articles
Published: October 11th 2024 | Updated: October 18th 2024
Buy, Sell, Hold: Cell and Gene Therapy - Part 1
Published: September 10th 2024 | Updated: September 18th 2024
CPHI Milan Announces 2024 CPHI Pharma Award Finalists
Published: August 21st 2024 | Updated: December 26th 2024
Pharmaceutical Technology Editorial Advisory Board
Published: November 25th 2024 | Updated: December 26th 2024
Leveraging Integrated Patient-Centric Innovations When Developing Today’s Biologics
Published: December 20th 2024 | Updated: December 26th 2024
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Published: February 23rd 2024 | Updated: December 26th 2024
Europa Perspectives: Helping to Navigate the Regulatory System
